Not Yet RecruitingNot Applicable

Dengue - Sample Collection Study Pakistan

200 participantsStarted 2025-10-01

Plain-language summary

The objective of this study is to collect well-characterized serum and plasma specimens from confirmed dengue positive and dengue negative subjects to support dengue diagnostic products development.

Who can participate

Age range12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥12-years-old * Individuals suspected or confirmed for active dengue, with dengue-consistent symptoms onset up to and including 10 days before enrolment in this trial. Exclusion Criteria: * Subject has been vaccinated for dengue. * Subject participates in an investigative drug, vaccine or medical device clinical study * Participant is deemed unfit for the study by the Investigator * Participant is unwilling or unable to provide informed consent

What they're measuring

sample collection only, no specific outcome needed

Timeframe: 5 months

Trial details

NCT IDNCT07203183

SponsorAbbott Rapid Dx

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-03-01

Contact for this trial

Simon Kordowich, PHD

+353 (0)91 429 900 info@abbott.com

View on ClinicalTrials.gov More Dengue trials